Point72 Middle East FZE’s Omnicell OMCL Stock Holding History

Point72 Middle East FZE’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,395	Closed	-$354K	–	938
2023 Q4	$354K	Buy	+9,395	New	+$346K	0.01%	916

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Middle East FZE's OMCL Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Omnicell (OMCL) in Q1 2024, closing a stake of 9,395 shares — an estimated $354K sold.

Point72 Middle East FZE first reported a position in OMCL in Q4 2023 and held it in 1 quarter. The position peaked at $354K in Q4 2023. 266 funds tracked by Wall St. Rank hold OMCL as of Q1 2024.

Point72 Middle East FZE reported no remaining Omnicell position as of Q1 2024 after selling out during the quarter.
Point72 Middle East FZE sold 9,395 Omnicell shares in Q1 2024, an estimated $354K.
Point72 Middle East FZE first reported a position in Omnicell in Q4 2023 and held it in 1 quarter.
Point72 Middle East FZE's Omnicell position peaked at $354K in Q4 2023.
266 funds tracked by Wall St. Rank held Omnicell as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.